期刊文献+

^(18)F-FDG和^(18)F-FLT PET显像SUV在肺结块诊断中的价值 被引量:3

The value of SUV in ^(18)F-FDG and ^(18)F-FLT PET imaging for diagnosing pulmonary nodules
下载PDF
导出
摘要 目的:探讨18F-氟氏脱氧葡萄糖(18F-FDG)和18F-氟氏胸腺嘧啶(18F-FLT)PET显像诊断肺结块的影响因素,以提高PET/CT对肺结块的诊断价值。方法:选择肺结块患者55例为研究对象,其中28例为肺内孤立结块,其余为2~3个结块,结块大小0.6~11.0cm。所有患者均行肺部18 F-FDG和18 F-FLT PET/CT检查,检查结果按不同性别、年龄、结块大小及病理类型进行分组,以各组18F-FDG和18F-FLT显像标准摄取值(SUV)的均数为界定标准,分析SUV与肺结块患者的性别、年龄、结块大小及病理类型等相互关系。结果:55例肺结块患者,不同性别、年龄、结块大小患者的18 F-FDG和18F-FLT显像SUV差异均无统计学意义(P>0.05),不同病理类型患者的18 F-FDG显像SUV差异无统计学意义(P>0.05),而不同病理类型患者的18F-FLT显像SUV差异有统计学意义(P<0.05)。结论:肺结块患者结块的病理类型是影响18F-FLT显像SUV的重要因素,18F-FLT PET/CT显像SUV鉴别诊断肺结块良恶性具有重要的价值和意义。 Objective:The study aims to investigate the diagnostic performance of dual-tracer 18F- fluorodeoxyglucose (18 F-FDG) and 18 F-fluorothymidine (18 F-FLT) PET/CT in pulmonary nodules, to differentiate the malignant tissue from benign pulmonary nodules. Methods: To choose 55 patients with pulmonary nodules as study target. In all cases, 28 cases were pulmonary nodules alone,others were 2 or 3 pulmonary nodules,and the sizes were 0.6- 11.0 cm. 18 F-FDG and 18 F- FLT PET/CT were performed in 55 patients. The groups of results were showed with sex, age, size and pathology of all pulmonary nodule patients, the define standard was according to SUV of every group on average. To study the affect of SUV of 18 F-FDG and 18 F-FLT with all groups. Results: There were no significant differences between the SUV of 18F FDG and sex, age, diameter of the nodule, type of the pathologic nature of nodule of all fifty-five patients (P〉0.05), however, there were significant differences between the SUV of 18FFLT and the type of pathologic nature of nodules of all fifty-five pa- tients (P〈0.05). Conclusion: The study showed that 18 F-FLT PET/CT SUV can accurately differentiate carcinoma from benign nodules.
出处 《放射学实践》 2012年第8期917-919,共3页 Radiologic Practice
关键词 氟脱氧葡萄糖F18 正电子发射断层摄影术 肺肿瘤 Fluorodeoxyglucose F18 18 F-fluorothymidine Positron-emission tomography Lung neoplasms
  • 相关文献

参考文献3

二级参考文献63

  • 1Christman D, Crawford EJ, Friedkin M, et al. Detection of DNA synthesis in intact organisms with positron-emitting [ methyl-11 C ] thymidine. Proc Nat Acad Sci, 1972, 69: 988-992.
  • 2Crawford EJ, Christman D, Atkins H, et al. Scintigraphy with positron-emitting compounds llC labeled thymidine and thymidylate. Int Nucl Med Biol, 1978, 5: 61-69.
  • 3Gardelle O, Roelcke U, Vontobel P, et al. [ 76Br] bromodeoxyufidine PET in tumor-bearing animals. Nucl Med Biol, 2001,28 : 51- 57.
  • 4Lu L, Sammuelsson L, Bergstrom M, et al. Rat studies comparing 11C-FMAU,18F-FLT, and 76BrFU as proliferation makers. J Nucl Med, 2002, 43: 1688-1698.
  • 5Mier W, Haberkorn U, Eisenhut M. 18F-FLT: portrait of a proliferation marker. Eur J Nucl Med, 2002, 29: 165-169.
  • 6Shields AF, Dohmen BM, Mangner TJ, et al. Metabolism of 18FFLT in patients. J Nucl Med, 2000, 4l Suppl: 36.
  • 7Barthel H, Perumal M, Latigo J, et al. The uptake of 3'-deoxy- 3'-18F-fluorothymidine into LS178Y tumours in vivo is dependent on thymidine kinase 1 protein levels. Eur J Nucl Med Mol Imaging, 2005, 32: 257-263.
  • 8Coppock DL, Pardee AB. Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol, 1987, 7 : 2925-2932.
  • 9Hengstschlager M, Oliver P, Hengstshlager-Ottnad E, et al. Loss of the p16/MTS1 tumor suppressor gene causes E2F mediated deregulation of essential enzymes of the DNA precursor metabolism. DNA Cell Biol, 1996, 15: 41-51.
  • 10Dunagan D, Chin R Jr, McCain T, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest, 2001, 119 : 333-339.

共引文献30

同被引文献22

  • 1倪颖梦,时国朝,万欢英,陈克敏,吴达明.CT引导下经皮肺穿刺的安全性及其影响因素[J].中国呼吸与危重监护杂志,2011,10(2):162-167. 被引量:32
  • 2戚乐,黄峰,陈小启,钱琦.CT导引下经皮肺部肿块穿刺活检术的临床应用研究[J].实用放射学杂志,2005,21(12):1266-1268. 被引量:24
  • 3Sivrikoz C M, Ak I,Simsek F S, et al. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non small cell lung carcinoma[J]. Thorac Cardiovasc Surg,2012, 60(2): 116-121.
  • 4Li X, Zhang H, Xing L,el al. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study[J]. Radiother Oneol,2012,102(2): 246-250.
  • 5Azad A, Chionh F, Scott A M, et al . High Impact of 18F FDG PET on management and prognostic stratification of newly diag nosed small cell lung cancer[J]. Mol Imaging Biol, 2010, 12 (4) 443-451.
  • 6Ak I,Sivrikoz M C, Entok E, et al. Discordant findings in patients with non-small-cell lung cancer: absolutely normal hone scans versus disseminated bone metastases on positron-emission tomo- graphy/computed tomography[J]. Eur J Cardiothorac Surg, 2010, 37(4) :792-796.
  • 7Nakamura K, Hongo A, Kodama J, et al. The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer[J]. Acta Med Okayama, 2012, 66(1): 53-60.
  • 8Nguyen, N C, Kaushik A, Wolverson M K,et al. Is there a com- mon SUV threshoId in oncological FDG PET/CT, at least for some common indications? a retrospective study[J]. Acta Oncol, 2011,50(5) : 670-677.
  • 9Port J L, Andrade R S, Levin M A. Positron emission tomo- graphic scanning in the diagnosis and staging of non-small cell lung cancer 2cm in size or less[J]. J Thorac Cardiovasc Surg, 2005,130(6) : 1611 - 1615.
  • 10田葵,秦立新,沙晋璐.CT定位下耐多药空洞型肺结核穿刺注药术探讨[J].实用放射学杂志,2007,23(12):1680-1682. 被引量:3

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部